- Home
- VVV vs MMSI Comparison
VVV vs MMSI Comparison
Compare VVV & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVV
- MMSI
- Stock Information
- Founded
- VVV 1866
- MMSI 1987
- Country
- VVV United States
- MMSI United States
- Employees
- VVV N/A
- MMSI N/A
- Industry
- VVV Major Chemicals
- MMSI Medical/Dental Instruments
- Sector
- VVV Industrials
- MMSI Health Care
- Exchange
- VVV Nasdaq
- MMSI Nasdaq
- Market Cap
- VVV 4.0B
- MMSI 4.8B
- IPO Year
- VVV 2016
- MMSI 1990
- Fundamental
- Price
- VVV $31.46
- MMSI $85.27
- Analyst Decision
- VVV Buy
- MMSI Strong Buy
- Analyst Count
- VVV 12
- MMSI 8
- Target Price
- VVV $42.83
- MMSI $105.38
- AVG Volume (30 Days)
- VVV 1.7M
- MMSI 648.0K
- Earning Date
- VVV 11-19-2025
- MMSI 10-30-2025
- Dividend Yield
- VVV N/A
- MMSI N/A
- EPS Growth
- VVV 68.45
- MMSI N/A
- EPS
- VVV 2.14
- MMSI 1.95
- Revenue
- VVV $1,692,000,000.00
- MMSI $1,477,128,000.00
- Revenue This Year
- VVV $6.79
- MMSI $13.38
- Revenue Next Year
- VVV $13.19
- MMSI $6.50
- P/E Ratio
- VVV $14.67
- MMSI $43.61
- Revenue Growth
- VVV 7.53
- MMSI 11.41
- 52 Week Low
- VVV $30.77
- MMSI $78.12
- 52 Week High
- VVV $43.20
- MMSI $111.45
- Technical
- Relative Strength Index (RSI)
- VVV 33.55
- MMSI 49.27
- Support Level
- VVV $30.77
- MMSI $85.29
- Resistance Level
- VVV $32.47
- MMSI $90.16
- Average True Range (ATR)
- VVV 0.82
- MMSI 2.65
- MACD
- VVV 0.04
- MMSI 0.11
- Stochastic Oscillator
- VVV 20.60
- MMSI 51.82
About VVV Valvoline Inc.
Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.